SIGMA Healthcare is set to continue opening up to 30 new stores in Australia each year, the company revealed in its first trading update since Chemist Warehouse completed its reverse takeover of the group.
While exact figures were not revealed, Sigma's pre-tax earnings for the combined group increased by 36% for the nine months to the end of Mar.
The company said the results are consistent with what Chemist Warehouse reported for the first half (an EBIT of $446.1 million), minus the costs of the merger.
The pharmacy giant expects to deliver double-digit sales growth, Chief Financial Officer Mark Davis explained at the Macquarie Australia Conference yesterday.
"The strong momentum has been continuing," he said.
"We have been seeing broadly consistent impacts in terms of trading conditions, still achieving double-digit sales growth.
"The GLP-1s [weight-loss drugs] are proving to be very popular," he added.
Davis also shared that, while Sigma is focused on its domestic rollout strategy, it will also continue expanding its international footprint.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 25
